Drug Type Small molecule drug |
Synonyms N 6022, N6022 |
Target |
Mechanism GSNOR inhibitors(S-nitrosoglutathione reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22N4O3 |
InChIKeyYVPGZQLRPAGKLA-UHFFFAOYSA-N |
CAS Registry1208315-24-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | US | 01 Mar 2011 | |
Cystic Fibrosis | Phase 1 | US | 01 Feb 2014 | |
Inflammatory Bowel Diseases | Preclinical | US | - | |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | - |
Phase 1 | 66 | ufvyxpbvpv(dfuvystsnw) = cyzumqizfx zoqcicihac (bxsdlxfnmw, lqorsbeijl - cpxkjdbubg) View more | - | 24 Nov 2014 | |||
Phase 1 | - | 41 | Placebo | efcppdnzjk(fsefrcfdci) = yoqympptis brmfrtuamn (lvcfwpxyfq, xvmouvtdzp - ragenqoqnx) View more | - | 07 Mar 2014 |